{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:42Z","timestamp":1786993542574,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.juro.2015.06.096","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T03:52:22Z","timestamp":1436068342000},"page":"1704-1707","source":"Crossref","is-referenced-by-count":49,"title":["Intralesional Injection of Interferon-\u03b12b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location"],"prefix":"10.1097","volume":"194","author":[{"given":"Carrie A.","family":"Stewart","sequence":"first","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Knoedler","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree H.","family":"Mandava","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"McCaslin","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premsant","family":"Sangkum","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Sikka","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Trost","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne J.G.","family":"Hellstrom","sequence":"additional","affiliation":[{"name":"Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana"},{"name":"Department of Urology, Mayo Clinic (LT), Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.06.096_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4321\/S0004-06142007000300021","article-title":"The natural history of Peyronie's disease","volume":"60","author":"Grasso","year":"2007","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a\u00a0large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.06.096_bib3","first-page":"2350","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/j.1939-4640.2000.tb03387.x","article-title":"Peyronie's disease: etiology, medical, and surgical therapy","volume":"21","author":"Hellstrom","year":"2000","journal-title":"J Androl"},{"key":"10.1016\/j.juro.2015.06.096_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.juro.2015.06.096_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib9","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2013.05.022","article-title":"Outcomes of intralesional interferon-alpha2B for the treatment of Peyronie's disease","volume":"190","author":"Trost","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5347(17)35996-7","article-title":"Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation","volume":"149","author":"Lee","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie's disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib12","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.06.096_bib14","unstructured":"Berookhim B, Chevinsky M, Jakubowski C et\u00a0al: Ventral intralesional verapamil injections for Peyronie's disease: feasibility and safety. Presented at annual meeting of Sexual Medicine Society of North America, Miami, Florida, November 21, 2014, abstract 74."},{"key":"10.1016\/j.juro.2015.06.096_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","article-title":"Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma","volume":"25","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2015.06.096_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000475057","article-title":"Treatment of Peyronie's disease with local interferon-alpha 2b","volume":"28","author":"Wegner","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.06.096_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/j.1939-4640.1999.tb02539.x","article-title":"A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease","volume":"20","author":"Ahuja","year":"1999","journal-title":"J Androl"},{"key":"10.1016\/j.juro.2015.06.096_bib18","first-page":"40","article-title":"Intralesional interferon in the treatment of Peyronie's disease: a pilot study","volume":"79","author":"Judge","year":"1997","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2015.06.096_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(05)00063-7","article-title":"Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature","volume":"175","author":"Greenfield","year":"2006","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715043116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715043116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.06.096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:18:38Z","timestamp":1748467118000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.06.096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1016\/j.juro.2015.06.096"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.06.096","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725618223.793523267","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}